Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$9.02 - $10.29 $105,579 - $120,444
11,705 New
11,705 $116,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $170,831 - $207,428
-14,130 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $7,897 - $9,017
-596 Reduced 4.05%
14,130 $191,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $10,505 - $13,081
-810 Reduced 5.21%
14,726 $210,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $15,193 - $20,727
-1,118 Reduced 6.71%
15,536 $217,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $238,152 - $312,095
16,654 New
16,654 $312,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.